Healthy donors vaccinated against HPV to help fight cancer in transplant patients
NCT ID NCT06508138
First seen Mar 09, 2026 · Last updated May 23, 2026 · Updated 13 times
Summary
This study enrolls healthy relatives of patients with advanced HPV-related head and neck cancer. Donors receive a therapeutic HPV vaccine to boost their immune cells against HPV. These cells are then collected and used in a separate transplant or cell infusion to treat the patient. The goal is to see if the vaccine is safe and effective in donors, with the hope of improving cancer control in recipients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, 21287, United States
Conditions
Explore the condition pages connected to this study.